Review



mab 1c3 antibody  (Millipore)


Bioz Verified Symbol Millipore is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Millipore mab 1c3 antibody
    Mab 1c3 Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mab+1c3+antibody/mab+1c2+antibody/10__1523_slash_jneurosci__3937___08__2009-62-37-40
    Average 90 stars, based on 1 article reviews
    mab 1c3 antibody - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Labeling:

    Article Title: The FXG: A Presynaptic Fragile X Granule Expressed in a Subset of Developing Brain Circuits
    Article Snippet: For labeling of FMRP, the following antibodies and concentrations were used: mAb 2F5-1 [1:1; raised against a H6 fusion of 1–200 aa human FMRP protein; A. Tartakoff, Case Western Reserve University, Cleveland, OH; Gabel et al. (2004)], mAb 1C3 (1:500; Millipore) or 7G1-1 (1:1; identifying amino acids 354 –368 of human FMRP; Developmental Studies Hybridoma Bank).

    Western Blot:

    Article Title: The FXG: A Presynaptic Fragile X Granule Expressed in a Subset of Developing Brain Circuits
    Article Snippet: For labeling of FMRP, the following antibodies and concentrations were used: mAb 2F5-1 [1:1; raised against a H6 fusion of 1–200 aa human FMRP protein; A. Tartakoff, Case Western Reserve University, Cleveland, OH; Gabel et al. (2004)], mAb 1C3 (1:500; Millipore) or 7G1-1 (1:1; identifying amino acids 354 –368 of human FMRP; Developmental Studies Hybridoma Bank).



    Similar Products

    90
    GenScript corporation mab 1c3 antibody
    Mab 1c3 Antibody, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mab+1c3+antibody/mab+1c3+antibody/pm40020261-77-7-41
    Average 90 stars, based on 1 article reviews
    mab 1c3 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Zalgen Labs human monoclonal antibody (mab) 9.20.1c3 anti-ebov glycoprotein (gp) 1 and 2 (gp 1,2 ) “1c3
    a Complete timeline starting with baseline (BL) assessment and ending at necropsy on day 99. Presence of ocular clinical signs and collection of aqueous humor through anterior chamber paracentesis are indicated with dots that are called out with indicator lines. EBOV GP genome equivalents (GEq) in sera, determined by RT-qPCR (red triangles), along with rhesus monkey-specific anti-EBOV GP IgG antibodies in serum detected by ELISA (orange dots). LOD, limit of detection of assay. b Clinical euthanasia scores recorded via cageside observation. Therapeutic human monoclonal antibody <t>1C3</t> dosing schedule is indicated with arrows. c Concentrations of aspartate aminotransferase (AST) and platelet counts determined in blood are shown over time. d Edema, eyelid splinting, anterior chamber fibrin clot, and iris vessel dilation visible from day 21 through day 30. e Photographs of the right (OD) and left (OS) eyes, documenting vitreous haze OS with improvement over time. f Precontrast and post-contrast magnetic resonance (MR) images of the globes. Volumetric measurements of both eyes extrapolated from MR scans show decreased eye volume OS, suggestive of hypotony. D; day.
    Human Monoclonal Antibody (Mab) 9.20.1c3 Anti Ebov Glycoprotein (Gp) 1 And 2 (Gp 1,2 ) “1c3, supplied by Zalgen Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mab+1c3+antibody/9+20+1c3+anti+ebov+gp1+2+antibody/pmc09644391-152-41-42
    Average 90 stars, based on 1 article reviews
    human monoclonal antibody (mab) 9.20.1c3 anti-ebov glycoprotein (gp) 1 and 2 (gp 1,2 ) “1c3 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Abnova agr2 mab 1c3 antibody
    a Complete timeline starting with baseline (BL) assessment and ending at necropsy on day 99. Presence of ocular clinical signs and collection of aqueous humor through anterior chamber paracentesis are indicated with dots that are called out with indicator lines. EBOV GP genome equivalents (GEq) in sera, determined by RT-qPCR (red triangles), along with rhesus monkey-specific anti-EBOV GP IgG antibodies in serum detected by ELISA (orange dots). LOD, limit of detection of assay. b Clinical euthanasia scores recorded via cageside observation. Therapeutic human monoclonal antibody <t>1C3</t> dosing schedule is indicated with arrows. c Concentrations of aspartate aminotransferase (AST) and platelet counts determined in blood are shown over time. d Edema, eyelid splinting, anterior chamber fibrin clot, and iris vessel dilation visible from day 21 through day 30. e Photographs of the right (OD) and left (OS) eyes, documenting vitreous haze OS with improvement over time. f Precontrast and post-contrast magnetic resonance (MR) images of the globes. Volumetric measurements of both eyes extrapolated from MR scans show decreased eye volume OS, suggestive of hypotony. D; day.
    Agr2 Mab 1c3 Antibody, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mab+1c3+antibody/anti+agr2/pm22072305-106-2-8
    Average 90 stars, based on 1 article reviews
    agr2 mab 1c3 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Millipore mab 1c3 antibody
    a Complete timeline starting with baseline (BL) assessment and ending at necropsy on day 99. Presence of ocular clinical signs and collection of aqueous humor through anterior chamber paracentesis are indicated with dots that are called out with indicator lines. EBOV GP genome equivalents (GEq) in sera, determined by RT-qPCR (red triangles), along with rhesus monkey-specific anti-EBOV GP IgG antibodies in serum detected by ELISA (orange dots). LOD, limit of detection of assay. b Clinical euthanasia scores recorded via cageside observation. Therapeutic human monoclonal antibody <t>1C3</t> dosing schedule is indicated with arrows. c Concentrations of aspartate aminotransferase (AST) and platelet counts determined in blood are shown over time. d Edema, eyelid splinting, anterior chamber fibrin clot, and iris vessel dilation visible from day 21 through day 30. e Photographs of the right (OD) and left (OS) eyes, documenting vitreous haze OS with improvement over time. f Precontrast and post-contrast magnetic resonance (MR) images of the globes. Volumetric measurements of both eyes extrapolated from MR scans show decreased eye volume OS, suggestive of hypotony. D; day.
    Mab 1c3 Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mab+1c3+antibody/mab+1c2+antibody/10__1523_slash_jneurosci__3937___08__2009-62-37-40
    Average 90 stars, based on 1 article reviews
    mab 1c3 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Millipore mouse antifmrp mab (monoclonal antibody) 2160 clone 1c3
    a Complete timeline starting with baseline (BL) assessment and ending at necropsy on day 99. Presence of ocular clinical signs and collection of aqueous humor through anterior chamber paracentesis are indicated with dots that are called out with indicator lines. EBOV GP genome equivalents (GEq) in sera, determined by RT-qPCR (red triangles), along with rhesus monkey-specific anti-EBOV GP IgG antibodies in serum detected by ELISA (orange dots). LOD, limit of detection of assay. b Clinical euthanasia scores recorded via cageside observation. Therapeutic human monoclonal antibody <t>1C3</t> dosing schedule is indicated with arrows. c Concentrations of aspartate aminotransferase (AST) and platelet counts determined in blood are shown over time. d Edema, eyelid splinting, anterior chamber fibrin clot, and iris vessel dilation visible from day 21 through day 30. e Photographs of the right (OD) and left (OS) eyes, documenting vitreous haze OS with improvement over time. f Precontrast and post-contrast magnetic resonance (MR) images of the globes. Volumetric measurements of both eyes extrapolated from MR scans show decreased eye volume OS, suggestive of hypotony. D; day.
    Mouse Antifmrp Mab (Monoclonal Antibody) 2160 Clone 1c3, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mab+1c3+antibody/mouse+antifmrp+mab++monoclonal+antibody++2160+clone+1c3/10__1042_slash_bj20050792-55-18-19
    Average 90 stars, based on 1 article reviews
    mouse antifmrp mab (monoclonal antibody) 2160 clone 1c3 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Millipore mouse anti-fmrp mab (monoclonal antibody) 2160 1c3
    a Complete timeline starting with baseline (BL) assessment and ending at necropsy on day 99. Presence of ocular clinical signs and collection of aqueous humor through anterior chamber paracentesis are indicated with dots that are called out with indicator lines. EBOV GP genome equivalents (GEq) in sera, determined by RT-qPCR (red triangles), along with rhesus monkey-specific anti-EBOV GP IgG antibodies in serum detected by ELISA (orange dots). LOD, limit of detection of assay. b Clinical euthanasia scores recorded via cageside observation. Therapeutic human monoclonal antibody <t>1C3</t> dosing schedule is indicated with arrows. c Concentrations of aspartate aminotransferase (AST) and platelet counts determined in blood are shown over time. d Edema, eyelid splinting, anterior chamber fibrin clot, and iris vessel dilation visible from day 21 through day 30. e Photographs of the right (OD) and left (OS) eyes, documenting vitreous haze OS with improvement over time. f Precontrast and post-contrast magnetic resonance (MR) images of the globes. Volumetric measurements of both eyes extrapolated from MR scans show decreased eye volume OS, suggestive of hypotony. D; day.
    Mouse Anti Fmrp Mab (Monoclonal Antibody) 2160 1c3, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mab+1c3+antibody/mouse+anti+fmrp/pmc01316289-140-18-19
    Average 90 stars, based on 1 article reviews
    mouse anti-fmrp mab (monoclonal antibody) 2160 1c3 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson mouse anti-human cd58 monoclonal antibody (mab), 1c3 (aicd58.6) (igg2a
    a Complete timeline starting with baseline (BL) assessment and ending at necropsy on day 99. Presence of ocular clinical signs and collection of aqueous humor through anterior chamber paracentesis are indicated with dots that are called out with indicator lines. EBOV GP genome equivalents (GEq) in sera, determined by RT-qPCR (red triangles), along with rhesus monkey-specific anti-EBOV GP IgG antibodies in serum detected by ELISA (orange dots). LOD, limit of detection of assay. b Clinical euthanasia scores recorded via cageside observation. Therapeutic human monoclonal antibody <t>1C3</t> dosing schedule is indicated with arrows. c Concentrations of aspartate aminotransferase (AST) and platelet counts determined in blood are shown over time. d Edema, eyelid splinting, anterior chamber fibrin clot, and iris vessel dilation visible from day 21 through day 30. e Photographs of the right (OD) and left (OS) eyes, documenting vitreous haze OS with improvement over time. f Precontrast and post-contrast magnetic resonance (MR) images of the globes. Volumetric measurements of both eyes extrapolated from MR scans show decreased eye volume OS, suggestive of hypotony. D; day.
    Mouse Anti Human Cd58 Monoclonal Antibody (Mab), 1c3 (Aicd58.6) (Igg2a, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mab+1c3+antibody/anti+cd58/pm15345303-45-16-29
    Average 90 stars, based on 1 article reviews
    mouse anti-human cd58 monoclonal antibody (mab), 1c3 (aicd58.6) (igg2a - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    a Complete timeline starting with baseline (BL) assessment and ending at necropsy on day 99. Presence of ocular clinical signs and collection of aqueous humor through anterior chamber paracentesis are indicated with dots that are called out with indicator lines. EBOV GP genome equivalents (GEq) in sera, determined by RT-qPCR (red triangles), along with rhesus monkey-specific anti-EBOV GP IgG antibodies in serum detected by ELISA (orange dots). LOD, limit of detection of assay. b Clinical euthanasia scores recorded via cageside observation. Therapeutic human monoclonal antibody 1C3 dosing schedule is indicated with arrows. c Concentrations of aspartate aminotransferase (AST) and platelet counts determined in blood are shown over time. d Edema, eyelid splinting, anterior chamber fibrin clot, and iris vessel dilation visible from day 21 through day 30. e Photographs of the right (OD) and left (OS) eyes, documenting vitreous haze OS with improvement over time. f Precontrast and post-contrast magnetic resonance (MR) images of the globes. Volumetric measurements of both eyes extrapolated from MR scans show decreased eye volume OS, suggestive of hypotony. D; day.

    Journal: Communications Biology

    Article Title: Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkey

    doi: 10.1038/s42003-022-04158-2

    Figure Lengend Snippet: a Complete timeline starting with baseline (BL) assessment and ending at necropsy on day 99. Presence of ocular clinical signs and collection of aqueous humor through anterior chamber paracentesis are indicated with dots that are called out with indicator lines. EBOV GP genome equivalents (GEq) in sera, determined by RT-qPCR (red triangles), along with rhesus monkey-specific anti-EBOV GP IgG antibodies in serum detected by ELISA (orange dots). LOD, limit of detection of assay. b Clinical euthanasia scores recorded via cageside observation. Therapeutic human monoclonal antibody 1C3 dosing schedule is indicated with arrows. c Concentrations of aspartate aminotransferase (AST) and platelet counts determined in blood are shown over time. d Edema, eyelid splinting, anterior chamber fibrin clot, and iris vessel dilation visible from day 21 through day 30. e Photographs of the right (OD) and left (OS) eyes, documenting vitreous haze OS with improvement over time. f Precontrast and post-contrast magnetic resonance (MR) images of the globes. Volumetric measurements of both eyes extrapolated from MR scans show decreased eye volume OS, suggestive of hypotony. D; day.

    Article Snippet: After intramuscular (IM) inoculation with 1000 plaque-forming units (PFU) of Ebola virus/H. sapiens-tc/COD/1995/Kikwit-9510621 (EBOV; NR-50306, Lot 9510621, BEI Resources, USA), the monkey was administered 25 mg/kg of human monoclonal antibody (mAb) 9.20.1C3 anti-EBOV glycoprotein (GP) 1 and 2 (GP 1,2 ) (“1C3”; Zalgen Labs, Germantown, MD, USA) intravenously (IV) on days 4 and 7 post-exposure.

    Techniques: Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Detection Assay